Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leach, Joseph
NCT03854110: Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine	Recruiting	1	64	US	GP-2250, gemcitabine	Geistlich Pharma AG, Translational Drug Development	Pancreatic Cancer, Adult	09/24	12/24
NHLBI-MDS, NCT02775383: The National Myelodysplastic Syndromes (MDS) Study	Recruiting	N/A	3500	US, RoW	Therapeutic	National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)	Myelodysplastic Syndromes (MDS)	03/25	03/25
Flynn, Patrick J
No trials found